Auditory neuropathy-neural and synaptic mechanisms

Nature Reviews Neurology

Volumn 12, Issue 3, 2016, Pages 135-149

  Moser, Tobias ^a   Starr, Arnold ^b  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL; DYNAMIN; EXCITATORY AMINO ACID TRANSPORTER; MEMBRANE PROTEIN; OTOFERLIN PROTEIN; PERIPHERAL MYELIN PROTEIN 22; PROTEIN DFNB59; PROTEIN DIAPH3; PROTEIN OPA1; REGULATOR PROTEIN; SYNAPTOTAGMIN I; THIAMINE; UNCLASSIFIED DRUG; VESICULAR GLUTAMATE TRANSPORTER 3;

AGING; AUDITORY REHABILITATION; CLINICAL FEATURE; COCHLEA PROSTHESIS; ELECTRONEUROLOGY; HEARING AID; HEARING TEST; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; HYPERBILIRUBINEMIA; HYPOXIA; INNER HAIR CELL; MISSENSE MUTATION; MOLECULAR GENETICS; NEUROLOGIC DISEASE; NOISE; NONHUMAN; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; REVIEW; SENSORY NERVE; SPIRAL GANGLION; THIAMINE DEFICIENCY; VESTIBULOCOCHLEAR NERVE DISEASE; ANIMAL; AUDITORY NERVOUS SYSTEM; COCHLEAR NERVE; HEARING LOSS; HEARING LOSS, CENTRAL; METABOLISM; PATHOLOGY; SYNAPSE;

ANIMALS; AUDITORY PATHWAYS; COCHLEAR NERVE; HAIR CELLS, AUDITORY, INNER; HEARING LOSS; HEARING LOSS, CENTRAL; HUMANS; SYNAPSES;

EID: 84959368381     PISSN: 17594758     EISSN: 17594766     Source Type: Journal    
DOI: 10.1038/nrneurol.2016.10     Document Type: Review

References (143)

1. World Health Organization. Primary ear and hearing care training resource. Advanced level. [online], http://www.who.int/pbd/deafness/activities/hearing-care/advanced.pdf (2006
2. Starr A., Picton T. W., Sininger Y., Hood L. J., & Berlin C. I. Auditory neuropathy. Brain 119, 741-754 (1996
3. Zeng F. G., Kong Y. Y., Michalewski H. J., & Starr A. Perceptual consequences of disrupted auditory nerve activity. J. Neurophysiol. 93, 3050-3063 (2005
4. Moser T., et al. Diagnostik und therapie der auditorischen synaptopathie/neuropathie. HNO 54, 833-841 (in German) (2006
5. Sutton G. J., et al. Assessment and management of auditory neuropathy/auditory dys-synchrony: a recommended protocol. Newborn Hearing Screening Programme England) [online], https://www.escholar.manchester.ac.uk/uk-ac-man-scw: 1d33279 (2004
6. Starr A., Zeng F. G., Michalewski H. J., & Moser T. in The Senses: A Comprehensive Reference Vol 3. Ch. 23 (eds Basbaum A. I., et al.) 397-412 (Academic Press, 2008
7. Penido R. C., & Isaac M. L. Prevalence of auditory neuropathy spectrum disorder in an auditory health care service. Braz. J. Otorhinolaryngol. 79, 429-433 (2013
8. Rance G., et al. Clinical findings for a group of infants and young children with auditory neuropathy. Ear Hear. 20, 238-252 (1999
9. Foerst A., et al. Prevalence of auditory neuropathy/synaptopathy in a population of children with profound hearing loss. Int. J. Pediatr. Otorhinolaryngol. 70, 1415-1422 (2006
10. Rodríguez-Ballesteros M., et al. A multicenter study on the prevalence and spectrum of mutations in the otoferlin gene (OTOF) in subjects with nonsyndromic hearing impairment and auditory neuropathy. Hum. Mutat. 29, 823-831 (2008
11. Thirlwall A. S., Brown D. J., McMillan P. M., Barker S. E., & Lesperance M. M. Phenotypic characterization of hereditary hearing impairment linked to DFNA25. Arch. Otolaryngol. Head Neck Surg. 129, 830-835 (2003
12. Matthews G., & Fuchs P. The diverse roles of ribbon synapses in sensory neurotransmission. Nat. Rev. Neurosci. 11, 812-822 (2010
13. Bech-Hansen N. T., et al. Loss of function mutations in a calcium-channel α1-subunit gene in Xp11.23 cause incomplete X linked congenital stationary night blindness. Nat. Genet. 19, 264-267 (1998
14. Strom T. M., et al. An L type calcium-channel gene mutated in incomplete X linked congenital stationary night blindness. Nat. Genet. 19, 260-263 (1998
15. Zeitz C., et al. Mutations in CABP4, the gene encoding the Ca2+-binding protein 4, cause autosomal recessive night blindness. Am. J. Hum. Genet. 79, 657-667 (2006
16. Khimich D., et al. Hair cell synaptic ribbons are essential for synchronous auditory signalling. Nature 434, 889-894 (2005
17. Buran B. N., et al. Onset coding is degraded in auditory nerve fibers from mutant mice lacking synaptic ribbons. J. Neurosci. 30, 7587-7597 (2010
18. Jung S., et al. Disruption of adaptor protein 2 (AP 2) in cochlear hair cells impairs vesicle reloading of synaptic release sites and hearing. EMBO J. 34, 2686-2702 (2015
19. Pangrsic T., et al. Hearing requires otoferlin-dependent efficient replenishment of synaptic vesicles in hair cells. Nat. Neurosci. 13, 869-876 (2010
20. Parkinson N. J., et al. Mutant β-spectrin 4 causes auditory and motor neuropathies in quivering mice. Nat. Genet. 29, 61-65 (2001
21. Lacas-Gervais S., et al. βIVsigma;1 spectrin stabilizes the nodes of Ranvier and axon initial segments. J. Cell Biol. 166, 983-990 (2004
22. Wichmann C., & Moser T. Relating structure and function of inner hair cell ribbon synapses. Cell Tissue Res. 361, 95-114 (2015
23. Fuchs P. A. Time and intensity coding at the hair cell's ribbon synapse. J. Physiol. 566, 7-12 (2005
24. Moser T., Neef A., & Khimich D. Mechanisms underlying the temporal precision of sound coding at the inner hair cell ribbon synapse. J. Physiol. 576, 55-62 (2006
25. Pangršič, T., Reisinger E., & Moser T. Otoferlin: a multi C2 domain protein essential for hearing. Trends Neurosci. 35, 671-680 (2012
26. Nouvian R., et al. Exocytosis at the hair cell ribbon synapse apparently operates without neuronal SNARE proteins. Nat. Neurosci. 14, 411-413 (2011
27. Strenzke N., et al. Complexin I is required for high-fidelity transmission at the endbulb of held auditory synapse. J. Neurosci. 29, 7991-8004 (2009
28. Uthaiah R. C., & Hudspeth A. J. Molecular anatomy of the hair cell's ribbon synapse. J. Neurosci. 30, 12387-12399 (2010
29. Vogl C., et al. Unconventional molecular regulation of synaptic vesicle replenishment in cochlear inner hair cells. J. Cell. Sci. 128, 638-644 (2015
30. Roux I., et al. Otoferlin, defective in a human deafness form, is essential for exocytosis at the auditory ribbon synapse. Cell 127, 277-289 (2006
31. Seal R. P., et al. Sensorineural deafness and seizures in mice lacking vesicular glutamate transporter 3. Neuron 57, 263-275 (2008
32. Ruel J., et al. Impairment of SLC17A8 encoding vesicular glutamate transporter 3, VGLUT3, underlies nonsyndromic deafness DFNA25 and inner hair cell dysfunction in null mice. Am. J. Hum. Genet. 83, 278-292 (2008
33. Platzer J., et al. Congenital deafness and sinoatrial node dysfunction in mice lacking class D L type Ca2+ channels. Cell 102, 89-97 (2000
34. Brandt A., Striessnig J., & Moser T. Cav1. 3 channels are essential for development and presynaptic activity of cochlear inner hair cells. J. Neurosci. 23, 10832-10840 (2003
35. Geisler C. D. From Sound to Synapse: Physiology of the Mammalian Ear (Oxford Univ. Press, 1998
36. Rutherford M. A., & Moser T. in The Primary Auditory Neurons of the Mammalian Cochlea (eds Dabdoub A., et al.) 117-156 (Springer-Verlag, 2016
37. Mo Z. L., Adamson C. L., & Davis R. L. Dendrotoxin-sensitive K+ currents contribute to accommodation in murine spiral ganglion neurons. J. Physiol. 542, 763 (2002
38. Rutherford M. A., Chapochnikov N. M., & Moser T. Spike encoding of neurotransmitter release timing by spiral ganglion neurons of the cochlea. J. Neurosci. 32, 4773-4789 (2012
39. Glowatzki E., & Fuchs P. A. Transmitter release at the hair cell ribbon synapse. Nat. Neurosci. 5, 147-154 (2002
40. Chapochnikov N. M., et al. Uniquantal release through a dynamic fusion pore is a candidate mechanism of hair cell exocytosis. Neuron 17, 1389-1403 (2014
41. Hossain W. A., Antic S. D., Yang Y., Rasband M. N., & Morest D. K. Where is the spike generator of the cochlear nerve? Voltage-gated sodium channels in the mouse cochlea. J. Neurosci. 25, 6857-6868 (2005
42. Yasunaga S., et al. A mutation in OTOF, encoding otoferlin, a FER 1 like protein, causes DFNB9, a nonsyndromic form of deafness. Nat. Genet. 21, 363-369 (1999
43. Varga R., et al. OTOF mutations revealed by genetic analysis of hearing loss families including a potential temperature sensitive auditory neuropathy allele. J. Med. Genet. 43, 576-581 (2006
44. Marlin S., et al. Temperature-sensitive auditory neuropathy associated with an otoferlin mutation: deafening fever! Biochem. Biophys. Res. Commun. 394, 737-742 (2010
45. Wang D. Y., et al. Screening mutations of OTOF gene in Chinese patients with auditory neuropathy, including a familial case of temperature-sensitive auditory neuropathy. BMC Med. Genet. 11, 79 (2010
46. Romanos J., et al. Novel OTOF mutations in Brazilian patients with auditory neuropathy. J. Hum. Genet. 54, 382-385 (2009
47. Matsunaga T., et al. A prevalent founder mutation and genotype-phenotype correlations of OTOF in Japanese patients with auditory neuropathy. Clin. Genet. 82, 425-432 (2012
48. McNeil P. L., & Kirchhausen T. An emergency response team for membrane repair. Nat. Rev. Mol. Cell. Biol. 6, 499-505 (2005
49. Liu J., et al. Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy. Nat. Genet. 20, 31-36 (1998
50. Bansal D., et al. Defective membrane repair in dysferlin-deficient muscular dystrophy. Nature 423, 168-172 (2003
51. Jim?nez J. L., & Bashir R. In silico functional and structural characterisation of ferlin proteins by mapping disease-causing mutations and evolutionary information onto three-dimensional models of their C2 domains. J. Neurol. Sci. 260, 114-123 (2007
52. Johnson C. P., & Chapman E. R. Otoferlin is a calcium sensor that directly regulates SNARE-mediated membrane fusion. J. Cell Biol. 191, 187-197 (2010
53. Padmanarayana M., et al. Characterization of the lipid binding properties of Otoferlin reveals specific interactions between PI(4,5)P2 and the C2C and C2F domains. Biochemistry 53, 5023-5033 (2014
54. Ramakrishnan N. A., Drescher M. J., & Drescher D. G. Direct interaction of otoferlin with syntaxin 1A, SNAP 25, and the L type voltage-gated calcium channel Cav1.3. J. Biol. Chem. 284, 1364-1372 (2009
55. Helfmann S., et al. The crystal structure of the C2A domain of otoferlin reveals an unconventional top loop region. J. Mol. Biol. 406, 479-490 (2011
56. Fuson K., et al. Alternate splicing of dysferlin C2A confers Ca2+-dependent and Ca2+-independent binding for membrane repair. Structure 22, 104-115 (2014
57. Santarelli R., del Castillo I., Cama E., Scimemi P., & Starr A. Audibility, speech perception and processing of temporal cues in ribbon synaptic disorders due to OTOF mutations. Hear. Res. 330 (Pt B), 200-212 (2015
58. Reisinger E., et al. Probing the functional equivalence of otoferlin and synaptotagmin 1 in exocytosis. J. Neurosci. 31, 4886-4895 (2011
59. Dulon D., Safieddine S., Jones S. M., & Petit C. Otoferlin is critical for a highly sensitive and linear calcium-dependent exocytosis at vestibular hair cell ribbon synapses. J. Neurosci. 29, 10474-10487 (2009
60. Varga R., et al. Non-syndromic recessive auditory neuropathy is the result of mutations in the otoferlin (OTOF) gene. J. Med. Genet. 40, 45-50 (2003
61. Schwander M., et al. A forward genetics screen in mice identifies recessive deafness traits and reveals that pejvakin is essential for outer hair cell function. J. Neurosci. 27, 2163-2175 (2007
62. Wynne D. P., et al. Loudness adaptation accompanying ribbon synapse and auditory nerve disorders. Brain 136, 1626-1638 (2013
63. Duncker S. V., et al. Otoferlin couples to clathrin-mediated endocytosis in mature cochlear inner hair cells. J. Neurosci. 33, 9508-9519 (2013
64. Greene C. C., et al. DFNA25, a novel locus for dominant nonsyndromic hereditary hearing impairment, maps to 12q21 24. Am. J. Hum. Genet. 68, 254-260 (2001
65. Obholzer N., et al. Vesicular glutamate transporter 3 is required for synaptic transmission in zebrafish hair cells. J. Neurosci. 28, 2110-2118 (2008
66. Petek E., et al. Molecular characterization of a 12q22 q24 deletion associated with congenital deafness: confirmation and refinement of the DFNA25 locus. Am. J. Med. Genet. A 117A, 122-126 (2003
67. Baig S. M., et al. Loss of Cav1.3 (CACNA1D) function in a human channelopathy with bradycardia and congenital deafness. Nat. Neurosci. 14, 77-84 (2011
68. Surmeier D. J. Calcium, ageing, and neuronal vulnerability in Parkinson's disease. Lancet Neurol. 6, 933-938 (2007
69. McKinney B. C., & Murphy G. G. The L Type voltage-gated calcium channel Cav1.3 mediates consolidation, but not extinction, of contextually conditioned fear in mice. Learn. Mem. 13, 584-589 (2006
70. Neef J., et al. The Ca2+ channel subunit β2 regulates Ca2+ channel abundance and function in inner hair cells and is required for hearing. J. Neurosci. 29, 10730 (2009
71. Wycisk K. A., et al. Mutation in the auxiliary calcium-channel subunit CACNA2D4 causes autosomal recessive cone dystrophy. Am. J. Hum. Genet. 79, 973-977 (2006
72. Schrauwen I., et al. A mutation in CABP2, expressed in cochlear hair cells, causes autosomal-recessive hearing impairment. Am. J. Hum. Genet. 91, 636-645 (2012
73. Haeseleer F., et al. Essential role of Ca2+-binding protein 4, a Cav1.4 channel regulator, in photoreceptor synaptic function. Nat. Neurosci. 7, 1079-1087 (2004
74. Santarelli R., et al. OPA1 related auditory neuropathy: site of lesion and outcome of cochlear implantation. Brain 138, 563-576 (2015
75. Yu Wai-Man P., et al. Multi-system neurological disease is common in patients with OPA1 mutations. Brain 133, 771-786 (2010
76. La Morgia C., Carbonelli M., Barboni P., Sadun A. A., & Carelli V. Medical management of hereditary optic neuropathies. Front. Neurol. 5, 141 (2014
77. Alexander C., et al. OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nat. Genet. 26, 211-215 (2000
78. Delettre C., et al. Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat. Genet. 26, 207-210 (2000
79. Kasahara A., & Scorrano L. Mitochondria: from cell death executioners to regulators of cell differentiation. Trends Cell Biol. 24, 761-770 (2014
80. Ferr? M., et al. Molecular screening of 980 cases of suspected hereditary optic neuropathy with a report on 77 novel OPA1 mutations. Hum. Mutat. 30, E692-E705 (2009
81. Alavi M. V., et al. A splice site mutation in the murine Opa1 gene features pathology of autosomal dominant optic atrophy. Brain 130, 1029-1042 (2006
82. Starr A., Dong C. J., & Michalewski H. J. Brain potentials before and during memory scanning. Electroencephalogr. Clin. Neurophysiol. 99, 28-37 (1996
83. Starr A. Pathology and physiology of auditory neuropathy with a novel mutation in the MPZ gene (Tyr145→Ser). Brain 126, 1604-1619 (2003
84. Kabzińska D., et al. Late-onset Charcot-Marie-Tooth type 2 disease with hearing impairment associated with a novel Pro105Thr mutation in the MPZ gene. Am. J. Med. Genet. A 143A, 2196-2199 (2007
85. Verhagen W. I. M., et al. Sensorineural hearing impairment in patients with Pmp22 duplication, deletion, and frameshift mutations. Otol. Neurotol. 26, 405-414 (2005
86. Kovach M. J., et al. Anticipation in a unique family with Charcot-Marie-Tooth syndrome and deafness: delineation of the clinical features and review of the literature. Am. J. Med. Genet. 108, 295-303 (2002
87. Rance G., & Starr A. Pathophysiological mechanisms and functional hearing consequences of auditory neuropathy. Brain 138, 3141-3158 (2015
88. Delmaghani S., et al. Mutations in the gene encoding pejvakin, a newly identified protein of the afferent auditory pathway, cause DFNB59 auditory neuropathy. Nat. Genet. 38, 770-778 (2006
89. Borck G., et al. High frequency of autosomal-recessive DFNB59 hearing loss in an isolated Arab population in Israel. Clin. Genet. 82, 271-276 (2012
90. Ebermann I., et al. Truncating mutation of the DFNB59 gene causes cochlear hearing impairment and central vestibular dysfunction. Hum. Mutat. 28, 571-577 (2007
91. Hashemzadeh Chaleshtori M., et al. Novel mutations in the pejvakin gene are associated with autosomal recessive non-syndromic hearing loss in Iranian families. Clin. Genet. 72, 261-263 (2007
92. Collin R. W. J., et al. Involvement of DFNB59 mutations in autosomal recessive nonsyndromic hearing impairment. Hum. Mutat. 28, 718-723 (2007
93. Delmaghani S., et al. Hypervulnerability to sound exposure through impaired adaptive proliferation of peroxisomes. Cell 163, 894-906 (2015
94. Kim T. B., et al. A gene responsible for autosomal dominant auditory neuropathy (AUNA1) maps to 13q14-21. J. Med. Genet. 41, 872 (2004
95. Starr A., et al. A dominantly inherited progressive deafness affecting distal auditory nerve and hair cells. J. Assoc. Res. Otolaryngol. 5, 411-426 (2004
96. Schoen C. J., et al. Increased activity of Diaphanous homolog 3 (DIAPH3)/diaphanous causes hearing defects in humans with auditory neuropathy and in Drosophila. Proc. Natl Acad. Sci. USA 107, 13396-13401 (2010
97. Schoen C. J., Burmeister M., & Lesperance M. M. Diaphanous homolog 3 (Diap3) overexpression causes progressive hearing loss and inner hair cell defects in a transgenic mouse model of human deafness. PLoS ONE 8, e56520 (2013
98. Rance G., et al. Speech perception ability in individuals with Friedreich ataxia. Brain 131, 2002-2012 (2008
99. Kirkim G., Serbetcioglu B., Erdag T. K., & Ceryan K. The frequency of auditory neuropathy detected by universal newborn hearing screening program. Int. J. Pediatr. Otorhinolaryngol. 72, 1461-1469 (2008
100. Schulman-Galambos C., & Galambos R. Brain stem evoked response audiometry in newborn hearing screening. Arch. Otolaryngol. 105, 86-90 (1979
101. Oh W., et al. Association between peak serum bilirubin and neurodevelopmental outcomes in extremely low birth weight infants. Pediatrics 112, 773-779 (2003
102. Olds C., & Oghalai J. S. Audiologic impairment associated with bilirubin-induced neurologic damage. Semin. Fetal Neonatal Med. 20, 42-46 (2015
103. Smith C. M., Barnes G. P., Jacobson C. A., & Oelberg D. G. Auditory brainstem response detects early bilirubin neurotoxicity at low indirect bilirubin values. J. Perinatol. 24, 730-732 (2004
104. Amatuzzi M. G., et al. Selective inner hair cell loss in premature infants and cochlea pathological patterns from neonatal intensive care unit autopsies. Arch. Otolaryngol. Head Neck Surg. 127, 629-636 (2001
105. Uziel A., Marot M., & Pujol R. The Gunn rat: an experimental model for central deafness. Acta Otolaryngol. 95, 651-656 (1983
106. Haustein M. D., et al. Acute hyperbilirubinaemia induces presynaptic neurodegeneration at a central glutamatergic synapse. J. Physiol. 588, 4683-4693 (2010
107. Spencer R. F., Shaia W. T., Gleason A. T., Sismanis A., & Shapiro S. M. Changes in calcium-binding protein expression in the auditory brainstem nuclei of the jaundiced Gunn rat. Hear. Res. 171, 129-141 (2002
108. Attias J., Raveh E., Aizer-Dannon A., Bloch-Mimouni A., & Fattal-Valevski A. Auditory system dysfunction due to infantile thiamine deficiency: long-term auditory sequelae. Audiol. Neurootol. 17, 309-320 (2012
109. Oishi K., et al. Targeted disruption of Slc19a2, the gene encoding the high-affinity thiamin transporter Thtr 1, causes diabetes mellitus, sensorineural deafness and megaloblastosis in mice. Hum. Mol. Genet. 11, 2951-2960 (2002
110. Liberman M. C., Tartaglini E., Fleming J. C., & Neufeld E. J. Deletion of SLC19A2, the high affinity thiamine transporter, causes selective inner hair cell loss and an auditory neuropathy phenotype. J. Assoc. Res. Otolaryngol. 7, 211-217 (2006
111. Yang C. H., Schrepfer T., & Schacht J. Age-related hearing impairment and the triad of acquired hearing loss. Front. Cell. Neurosci. 9, 276 (2015
112. Henry W. R., & Mulroy M. J. Afferent synaptic changes in auditory hair cells during noise-induced temporary threshold shift. Hear. Res. 84, 81-90 (1995
113. Puel J. L., Pujol R., Ladrech S., & Eybalin M. α-amino 3 hydroxy-5 methyl-4 isoxazole propionic acid electrophysiological and neurotoxic effects in the guinea-pig cochlea. Neuroscience 45, 63-72 (1991
114. Puel J. L., Ruel J., Gervais d'Aldin C., & Pujol R. Excitotoxicity and repair of cochlear synapses after noise-trauma induced hearing loss. Neuroreport 9, 2109-2114 (1998
115. Stamataki S., Francis H. W., Lehar M., May B. J., & Ryugo D. K. Synaptic alterations at inner hair cells precede spiral ganglion cell loss in aging C57BL/6J mice. Hear. Res. 221, 104-118 (2006
116. Kujawa S. G., & Liberman M. C. Adding insult to injury: cochlear nerve degeneration after 'temporary' noise-induced hearing loss. J. Neurosci. 29, 14077 (2009
117. Sergeyenko Y., Lall K., Liberman M. C., & Kujawa S. G. Age-related cochlear synaptopathy: an early-onset contributor to auditory functional decline. J. Neurosci. 33, 13686-13694 (2013
118. Kujawa S. G., & Liberman M. C. Synaptopathy in the noise-exposed and aging cochlea: primary neural degeneration in acquired sensorineural hearing loss. Hear. Res. 330(Pt B), 191-199 (2015
119. Hakuba N., Koga K., Gyo K., Usami S. I., & Tanaka K. Exacerbation of noise-induced hearing loss in mice lacking the glutamate transporter GLAST. J. Neurosci. 20, 8750-8753 (2000
120. Meyer A. C., et al. Tuning of synapse number, structure and function in the cochlea. Nat. Neurosci. 12, 444-453 (2009
121. Furman A. C., Kujawa S. G., & Liberman M. C. Noise-induced cochlear neuropathy is selective for fibers with low spontaneous rates. J. Neurophysiol. 110, 577-586 (2013
122. Bourien J., et al. Contribution of auditory nerve fibers to compound action potential of the auditory nerve. J. Neurophysiol. 112, 1025-1039 (2014
123. Wan G., Gsigma;mez-Casati M. E., Gigliello A. R., Liberman M. C., & Corfas G. Neurotrophin 3 regulates ribbon synapse density in the cochlea and induces synapse regeneration after acoustic trauma. eLIFE 3, e03564 (2014
124. Schaette R., & McAlpine D. Tinnitus with a normal audiogram: physiological evidence for hidden hearing loss and computational model. J. Neurosci. 31, 13452-13457 (2011
125. Starr A., et al. Absence of both auditory evoked potentials and auditory percepts dependent on timing cues. Brain 114, 1157-1180 (1991
126. Starr A., et al. Cochlear receptor (microphonic and summating potentials, otoacoustic emissions) and auditory pathway (auditory brain stem potentials) activity in auditory neuropathy. Ear Hear. 22, 91 (2001
127. Santarelli R., et al. Abnormal cochlear potentials from deaf patients with mutations in the otoferlin gene. J. Assoc. Res. Otolaryngol. 10, 545-556 (2009
128. Pauli-Magnus D., et al. Detection and differentiation of sensorineural hearing loss in mice using auditory steady-state responses and transient auditory brainstem responses. Neuroscience 149, 673-684 (2007
129. Shearer A. E., & Smith R. J. H. Massively parallel sequencing for genetic diagnosis of hearing loss: the new standard of care. Otolaryngol. Head Neck Surg. 153, 175-182 (2015
130. Dean C., Felder G., & Kim A. H. Analysis of speech perception outcomes among patients receiving cochlear implants with auditory neuropathy spectrum disorder. Otol. Neurotol. 34, 1610-1614 (2013
131. Humphriss R., et al. Does cochlear implantation improve speech recognition in children with auditory neuropathy spectrum disorder? A systematic review. Int. J. Audiol. 52, 442-454 (2013
132. Roush P., Frymark T., Venediktov R., & Wang B. Audiologic management of auditory neuropathy spectrum disorder in children: a systematic review of the literature. Am. J. Audiol. 20, 159-170 (2011
133. Giraudet F., & Avan P. Auditory neuropathies: understanding their pathogenesis to illuminate intervention strategies. Curr. Opin. Neurol. 25, 50-56 (2012
134. Rance G., & Barker E. J. Speech and language outcomes in children with auditory neuropathy/dys-synchrony managed with either cochlear implants or hearing aids. Int. J. Audiol. 48, 313-320 (2009
135. Ching T. Y. C., et al. Impact of the presence of auditory neuropathy spectrum disorder (ANSD) on outcomes of children at three years of age. Int. J. Audiol. 52, S55-S64 (2013
136. Hall R. D. Estimation of surviving spiral ganglion cells in the deaf rat using the electrically evoked auditory brainstem response. Hear. Res. 49, 155-168 (1990
137. Hall R. D. Estimation of surviving spiral ganglion cells in the deaf rat using the electrically evoked auditory brainstem response. Hear. Res. 45, 123-136 (1990
138. Zhou R., Abbas P. J., & Assouline J. G. Electrically evoked auditory brainstem response in peripherally myelin-deficient mice. Hear Res. 88, 98-106 (1995
139. Rouillon I., et al. Results of cochlear implantation in two children with mutations in the OTOF gene. Int. J. Pediatr. Otorhinolaryngol. 70, 689-696 (2006
140. Hernandez V. H., et al. Optogenetic stimulation of the auditory pathway. J. Clin. Invest. 124, 1114-1129 (2014
141. Jeschke M., & Moser T. Considering optogenetic stimulation for cochlear implants. Hear. Res. 322, 224-234 (2015
142. Akil O., et al. Restoration of hearing in the VGLUT3 knockout mouse using virally mediated gene therapy. Neuron 75, 283-293 (2012
143. US National Library of Medicine. ClinicalTrials.gov [online] https://clinicaltrials.gov/ct2/show/NCT02132130 (2015